scott h. robbins
AstraZeneca (United States)
Wilmington, United States
Review Editor
NK and Innate Lymphoid Cell Biology
AstraZeneca (United States)
Wilmington, United States
Review Editor
NK and Innate Lymphoid Cell Biology
German Cancer Research Center (DKFZ)
Heidelberg, Germany
Review Editor
NK and Innate Lymphoid Cell Biology
Dana–Farber Cancer Institute
Boston, United States
Review Editor
NK and Innate Lymphoid Cell Biology
Genentech Inc.
San Francisco, United States
Review Editor
NK and Innate Lymphoid Cell Biology
Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet (KI)
Huddinge, Sweden
Review Editor
NK and Innate Lymphoid Cell Biology
Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences (IMS)
Yokohama, Japan
Review Editor
NK and Innate Lymphoid Cell Biology
Department of Infection and Immunity, Luxembourg Institute of Health
Esch-sur-Alzette, Luxembourg
Review Editor
NK and Innate Lymphoid Cell Biology
Fraunhofer Institute for Cell Therapy and Immunology (IZI)
Leipzig, Germany
Review Editor
NK and Innate Lymphoid Cell Biology
University of Bern
Bern, Switzerland
Review Editor
NK and Innate Lymphoid Cell Biology
King's College London
London, United Kingdom
Review Editor
NK and Innate Lymphoid Cell Biology
Sapienza University of Rome
Rome, Italy
Review Editor
NK and Innate Lymphoid Cell Biology
INSERM DR GO
Nantes, France
Review Editor
NK and Innate Lymphoid Cell Biology
Dartmouth College
Hanover, United States
Review Editor
NK and Innate Lymphoid Cell Biology
College of Veterinary Medicine
Tuguegarao, Philippines
Review Editor
NK and Innate Lymphoid Cell Biology
University of Tsukuba
Tsukuba, Japan
Review Editor
NK and Innate Lymphoid Cell Biology
National Eye Institute (NIH)
Bethesda, United States
Review Editor
NK and Innate Lymphoid Cell Biology